Blast Counts Not Enough to Distinguish MDS From AML, Experts Say
Oncologists argue that in differentiating myelodysplastic syndrome from acute myeloid leukemia, more than just bone marrow blast cutoff should be considered.
Medscape Medical News
source https://www.medscape.com/viewarticle/968413?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/968413?src=rss
Comments
Post a Comment